Eledon Pharmaceuticals Changes Auditors to BDO USA
Ticker: ELDN · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1404281
| Field | Detail |
|---|---|
| Company | Eledon Pharmaceuticals, Inc. (ELDN) |
| Form Type | 8-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
TL;DR
Eledon swapped accountants from CohnReznick to BDO USA, effective April 1st.
AI Summary
Eledon Pharmaceuticals, Inc. announced on April 1, 2025, a change in its certifying accountant. The company has appointed BDO USA, P.A. as its new independent registered public accounting firm, effective immediately. This change follows the resignation of CohnReznick LLP.
Why It Matters
A change in auditors can sometimes signal underlying issues or a strategic shift within a company, potentially impacting investor confidence.
Risk Assessment
Risk Level: low — This filing pertains to a routine change in the company's auditor, which typically carries low inherent risk.
Key Players & Entities
- Eledon Pharmaceuticals, Inc. (company) — Registrant
- BDO USA, P.A. (company) — New independent registered public accounting firm
- CohnReznick LLP (company) — Resigned independent registered public accounting firm
- April 01, 2025 (date) — Effective date of auditor change
FAQ
Who is Eledon Pharmaceuticals' new independent registered public accounting firm?
Eledon Pharmaceuticals, Inc. has appointed BDO USA, P.A. as its new independent registered public accounting firm.
When did the change in certifying accountant become effective?
The change in certifying accountant became effective on April 01, 2025.
Who was Eledon Pharmaceuticals' previous independent registered public accounting firm?
Eledon Pharmaceuticals, Inc.'s previous independent registered public accounting firm was CohnReznick LLP.
Did the company have any disagreements with its former accountant?
The filing does not mention any disagreements between Eledon Pharmaceuticals, Inc. and CohnReznick LLP.
What is the effective date of the report?
The date of the report, and the earliest event reported, is April 01, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding Eledon Pharmaceuticals, Inc. (ELDN).